These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7584951)

  • 1. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Caplen NJ; Alton EW; Middleton PG; Dorin JR; Stevenson BJ; Gao X; Durham SR; Jeffery PK; Hodson ME; Coutelle C
    Nat Med; 1995 Jan; 1(1):39-46. PubMed ID: 7584951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
    Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis.
    Noone PG; Hohneker KW; Zhou Z; Johnson LG; Foy C; Gipson C; Jones K; Noah TL; Leigh MW; Schwartzbach C; Efthimiou J; Pearlman R; Boucher RC; Knowles MR
    Mol Ther; 2000 Jan; 1(1):105-14. PubMed ID: 10933918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA
    Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
    Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
    Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
    Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
    Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.
    Alton EW; Stern M; Farley R; Jaffe A; Chadwick SL; Phillips J; Davies J; Smith SN; Browning J; Davies MG; Hodson ME; Durham SR; Li D; Jeffery PK; Scallan M; Balfour R; Eastman SJ; Cheng SH; Smith AE; Meeker D; Geddes DM
    Lancet; 1999 Mar; 353(9157):947-54. PubMed ID: 10459902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG; McElvaney NG; Herena J; Crystal RG
    Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.
    McLachlan G; Ho LP; Davidson-Smith H; Samways J; Davidson H; Stevenson BJ; Carothers AD; Alton EW; Middleton PG; Smith SN; Kallmeyer G; Michaelis U; Seeber S; Naujoks K; Greening AP; Innes JA; Dorin JR; Porteous DJ
    Gene Ther; 1996 Dec; 3(12):1113-23. PubMed ID: 8986438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo.
    Jiang C; O'Connor SP; Fang SL; Wang KX; Marshall J; Williams JL; Wilburn B; Echelard Y; Cheng SH
    Hum Gene Ther; 1998 Jul; 9(11):1531-42. PubMed ID: 9694152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
    Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
    Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.
    Moss RB; Rodman D; Spencer LT; Aitken ML; Zeitlin PL; Waltz D; Milla C; Brody AS; Clancy JP; Ramsey B; Hamblett N; Heald AE
    Chest; 2004 Feb; 125(2):509-21. PubMed ID: 14769732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.
    Yoshimura K; Rosenfeld MA; Nakamura H; Scherer EM; Pavirani A; Lecocq JP; Crystal RG
    Nucleic Acids Res; 1992 Jun; 20(12):3233-40. PubMed ID: 1377820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
    Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
    Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.
    Konstan MW; Davis PB; Wagener JS; Hilliard KA; Stern RC; Milgram LJ; Kowalczyk TH; Hyatt SL; Fink TL; Gedeon CR; Oette SM; Payne JM; Muhammad O; Ziady AG; Moen RC; Cooper MJ
    Hum Gene Ther; 2004 Dec; 15(12):1255-69. PubMed ID: 15684701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
    Cmielewski P; Donnelley M; Parsons DW
    J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.